Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyrrolidine derivatives as histamine H3 receptor antagonists

Pyrrolidine derivatives as histamine H3 receptor antagonists

US Patent 7951826 · Granted May 31, 2011

Estimated economic value: $157,980,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

[1,2,4]Triazolo derivatives as PDE1 inhibitors for the treatment of diabetes2022
MET antibody drug conjugates2021
Growth differentiation factor 15 agonist compounds and methods of using the same2021
Azetidinyloxyphenylpyrrolidine compounds2020
Notch pathway signaling inhibitor compounds2019
PDE1 inhibitor2018
6-substituted-3H-1,3-benzothiazol-2-one compounds as TARP-gamma 8 dependent AMPA2016
RAF inhibitor compounds2016
Raf inhibitor compounds2015
Disubstituted phthalazine hedgehog pathway antagonists2015
Glucagon receptor antagonists, preparation and therapeutic uses2014
Notch pathway signaling inhibitor compound2013